Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)
- 15 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 71 (3), 595-603
- https://doi.org/10.1007/s12020-021-02645-w
Abstract
Primary bilateral macronodular adrenal hyperplasia (PBMAH), characterized by bilateral benign adrenal macronodules (>1 cm) potentially responsible for variable levels of cortisol excess, is a rare and heterogeneous disease. However, its frequency increases due to incidentally diagnosed cases on abdominal imaging carried out for reasons other than suspected adrenal disease. Mostly isolated, it can also be associated with dominantly inherited genetic conditions in rare cases. Considering the bilateral nature of adrenal involvement and the description of familial cases, the search of a genetic predisposition has led to the identification of germline heterozygous inactivating mutations of the putative tumor suppressor gene ARMC5, causing around 25% of the apparent sporadic cases. Rigorous biochemical and imaging assessment are key elements in the management of this challenging disease in terms of diagnosis. Treatment is reserved for symptomatic patients with overt or subclinical Cushing syndrome, and was historically based on bilateral adrenalectomy, which nowadays tends to be replaced by unilateral adrenalectomy or lifelong treatment with cortisol synthesis inhibitors.Funding Information
- CARPEM
- Wellcome Trust (WT209492/Z/17/Z)
- Else Kröner-Fresenius-Stiftung (2012_A103 2015_A228)
This publication has 53 references indexed in Scilit:
- Characteristics of Adrenal Masses in Familial Adenomatous PolyposisDiseases of the Colon & Rectum, 2018
- A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotypeEndocrine, 2016
- ARMC5Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesJournal of Clinical Endocrinology & Metabolism, 2015
- ARMC5Mutations in Macronodular Adrenal Hyperplasia with Cushing's SyndromeThe New England Journal of Medicine, 2013
- Intraadrenal Corticotropin in Bilateral Macronodular Adrenal HyperplasiaThe New England Journal of Medicine, 2013
- Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell CancerJournal of Urology, 2013
- Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'étude des Tumeurs Endocrines databaseActa Endocrinologica, 2012
- Inactivation of theAPCGene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical CancersClinical Cancer Research, 2010
- Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasias (Corticotropin- Independent Cushing Syndrome)Endocrine development, 2008
- Cushing's Syndrome: Nodular Cortical Hyperplasia of Adrenal Glands with Clinical and Pathological Features Suggesting Adrenocortical TumorJournal of Clinical Endocrinology & Metabolism, 1964